50 related articles for article (PubMed ID: 38448009)
1. Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance.
Cui S; Guo Y; Li J; Bian W; Wu W; Zhang W; Zheng Q; Guan H; Wang J; Niu J
Ann Hematol; 2024 May; 103(5):1665-1673. PubMed ID: 38326481
[TBL] [Abstract][Full Text] [Related]
2. Risk-benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study.
Xiang QQ; Chu B; Lu MQ; Shi L; Gao S; Wang YT; Fang LJ; Ding YH; Zhao X; Chen Y; Wang MZ; Hu WK; Wang LF; Sun K; Bao L
Ann Hematol; 2023 Jun; 102(6):1513-1522. PubMed ID: 36997718
[TBL] [Abstract][Full Text] [Related]
3. Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Alzahrani K; Pasvolsky O; Wang Z; Milton DR; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Lee HC; Patel KK; Manasanch EE; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin R; Qazilbash MH
Br J Haematol; 2024 May; 204(5):1944-1952. PubMed ID: 38448009
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of the Second Revision of the International Staging System in patients with newly diagnosed transplant-eligible multiple myeloma].
Zhou HX; Jian Y; Du J; Liu JR; Zhang ZY; Geng CY; Yang GZ; Wang GR; Fu WJ; Li J; Chen WM; Gao W
Zhonghua Nei Ke Za Zhi; 2024 Jan; 63(1):81-88. PubMed ID: 38186122
[No Abstract] [Full Text] [Related]
5. [Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].
Yan J; Zhou DM; Shao XY; Xu Y; Chen B
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):170-177. PubMed ID: 38604794
[No Abstract] [Full Text] [Related]
6. Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS.
Guo W; Zhan A; Mery DE; Munshi MN; Makhoul O; Baily C; Zangari M; Tricot G; Peng H; Shaughnessy JD
Blood Adv; 2023 Nov; 7(21):6676-6684. PubMed ID: 37756524
[TBL] [Abstract][Full Text] [Related]
7. The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma.
Yang P; Zhou F; Dong Y; Gao G; Xue H; Liang X; Yu S; Xu W; Ma Y; Qin X; Li M; Dai Y; Jin F
Hemasphere; 2023 Apr; 7(4):e857. PubMed ID: 36999007
[No Abstract] [Full Text] [Related]
8. The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
Tan JLC; Wellard C; Moore EM; Mollee P; Rajagopal R; Quach H; Harrison SJ; McDonald EJ; Ho PJ; Prince HM; Augustson BM; Campbell P; McQuilten ZK; Wood EM; Spencer A;
Br J Haematol; 2023 Jan; 200(2):e17-e21. PubMed ID: 36321478
[No Abstract] [Full Text] [Related]
9. The applicability of the Second Revision of the International Staging System for patients with multiple myeloma receiving immunomodulatory drugs or proteasome inhibitor-based regimens as induction treatment: A real-world analysis.
Chen H; Zhou N; Hu X; Wang D; Wei W; Peng R; Chen X; Shi H; Wu L; Yu W; Zhao W; Zhou F
Hematol Oncol; 2023 Feb; 41(1):139-146. PubMed ID: 36252280
[TBL] [Abstract][Full Text] [Related]
10. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications.
Bernstein ZS; Kim EB; Raje N
Cells; 2022 Jul; 11(15):. PubMed ID: 35954151
[TBL] [Abstract][Full Text] [Related]
11. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
